BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VTIMEZONE
TZID:Eastern Standard Time
X-LIC-LOCATION:America/New_York
BEGIN:STANDARD
DTSTART:20231105T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:EST
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20240310T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:EDT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:2021 Annual Meeting by the ºÃÉ«ÏÈÉú\n\nTi
 tle: Industry Therapeutic Update from Bristol Myers Squibb: ZEPOSIA® (Oza
 nimod): A Once-Daily Oral Option for Patients with Relapsing Forms of MS\
 n\nAccess URL: /MSA/Public/Events/GetEventURL/13828\n\
 nLearn More About This Event: /MSA/Public/Events/Detai
 ls/13828
DTEND;TZID=Eastern Standard Time:20210418T140000
DTSTAMP:20250315T221755Z
DTSTART;TZID=Eastern Standard Time:20210418T130000
LOCATION:/MSA/Public/Events/GetEventURL/13828
SEQUENCE:0
SUMMARY:AAN: Industry Therapeutic Update from Bristol Myers Squibb: ZEPOSI
 A® (Ozanimod): A Once-Daily Oral Option for Patients with Relapsing Forms
  of MS
UID:da204a7a-c09c-47d3-8cac-81a65f503095
END:VEVENT
END:VCALENDAR